Complications of Intravitreal Ocriplasmin in the Treatment of Symptomatic Vitreomacular Adhesion

被引：0
|
作者：
Feng, Henry L. [1 ]
Roth, Daniel B. [1 ]
Modi, Kunjal K. [1 ]
Fine, Howard F. [1 ]
Wheatley, Harold M. [1 ]
机构：
[1] Robert Wood Johnson Med Sch, Piscataway, NJ USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
763; vitreous; 688; retina; 561; injection;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
308
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [21] Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion
    Stefanini, Francisco R.
    Maia, Mauricio
    Falabella, Paulo
    Pfister, Marcel
    Niemeyer, Moritz
    Kashani, Amir H.
    Humayun, Mark S.
    Koss, Michael J.
    CLINICAL OPHTHALMOLOGY, 2014, 8 : 847 - 856
  • [22] Early Evolution of the Vitreomacular Interface and Clinical Efficacy After Ocriplasmin Injection for Symptomatic Vitreomacular Adhesion
    Meyer, Jacob C.
    Shah, Gaurav K.
    Blinder, Kevin J.
    Waheed, Nadia K.
    Reichel, Elias
    Stalmans, Peter
    Singer, Michael
    Tewari, Asheesh
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (02): : 209 - 216
  • [23] Intravitreal gas for symptomatic vitreomacular adhesion: a synthesis of the literature
    Neffendorf, James E.
    Simpson, Andrew R. H.
    Steel, David H. W.
    Desai, Riti
    McHugh, Dominic A.
    Pringle, Edward
    Jackson, Timothy L.
    ACTA OPHTHALMOLOGICA, 2018, 96 (07) : 685 - 691
  • [24] Baseline Predictors of Vitreomacular Adhesion/Traction Resolution Following an Intravitreal Injection of Ocriplasmin
    Jackson, Timothy L.
    Regillo, Carl D.
    Girach, Aniz
    Dugel, Pravin U.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2016, 47 (08): : 716 - 723
  • [25] Updated Cost-Effectiveness of Intravitreal Ocriplasmin for Vitreomacular Adhesion and Macular Hole
    Waseem, Tayab
    Reinhart, Colin
    Wagner, Alan L.
    Kapoor, Kapil G.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2018, 49 (12): : E240 - E248
  • [26] Ocriplasmin for symptomatic vitreomacular adhesion: an evidence-based review of its potential
    Song, Su Jeong
    Smiddy, William E.
    CORE EVIDENCE, 2014, 9 : 51 - 59
  • [27] Cost-effectiveness analysis of ocriplasmin versus watchful waiting for treatment of symptomatic vitreomacular adhesion in the US
    Khanani, Arshad M.
    Dugel, Pravin U.
    Haller, Julia A.
    Wagner, Alan L.
    Lescrauwaet, Benedicte
    Schmidt, Ralph
    Bennison, Craig
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (04) : 287 - 306
  • [28] Ocriplasmin Treatment Leads to Symptomatic Vitreomacular Adhesion/Vitreomacular Traction Resolution in the Real-World Setting: The Phase IV ORBIT Study
    Khanani, Arshad M.
    Duker, Jay S.
    Heier, Jeffrey S.
    Kaiser, Peter K.
    Joondeph, Brian C.
    Kozma, Petra
    Rosberger, Daniel F.
    MacCumber, Mathew
    Boyer, David S.
    Pieramici, Dante J.
    OPHTHALMOLOGY RETINA, 2019, 3 (01): : 32 - 41
  • [29] One year retrospective analysis of ocriplasmin for the treatment of symptomatic vitreomacular traction
    Tacea, Filofteia
    Makris, Leonidas
    Kamal, Ahmed
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [30] Safety and Efficacy of Intravitreal Ocriplasmin in Diabetic Macular Edema with Vitreomacular Adhesion - results of a guided intravitreal injection method
    Coelho, Joao
    Pessoa, Bernardete
    Correia, Nuno Alves
    Beirao, Joao Melo
    Meireles, Angelina
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
12345